Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clear Rules Needed For Disclosing Clinical Trial Estimands

Executive Summary

Although estimands are a great tool for clarifying the treatment effects that are being investigated in a clinical trial, existing registries are not well suited for their public disclosure. Industry-wide guidance can help sponsors using different approaches. 

You may also be interested in...

Trial Protocol Harmonizing Initiative Promises More Consistency & Less Uncertainty

A globally harmonized template for clinical trial protocols would help sponsors develop protocols that are “well organized” and “free from ambiguity,” according to the International Council for Harmonisation.

Pharma Told To Get It Right First Time On Clinical Trial Data

Drug companies are complying with their obligation to submit clinical trial results to the US-based database, but major errors in their submissions prevent the results from being uploaded in a timely manner. 

ICH Consults On Harmonized Standards For Choosing Estimands In Clinical Trials

An addendum to the International Council for Harmonisation's guideline on statistical principles for clinical trials proposes a new framework on how the concept of estimands can be used to help clearly describe the effects of a medicine.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts